ANA Autoimmune Panel Reflex Crithidia

Test Code: TD_4884
CPT Code(s): 86038 (If Pos Add 86039), 86235 X8, 83516, 86376, 86160 X2, 86431, 86225

$20

Test Details

Alternative Name(s)

Antinuclear Antibody with reflex Crithidia Luciliae

Test Includes

Anti-nuclear antibodies
Autoimmune antibodies
Thyroid peroxidase AB
Complement C3
Complement C4
Rheumatoid factor, quant
DNA ds Antibody Reflex Crithidia

Methodology

Anti-nuclear antibodies: Indirect Immunofluorescent Assay (IFA) with human epithelial (hep-2) cell line substrate autoimmune antibodies, CCP IgG
DNA ds antibody: Multiplex Flow Immunoassay
Thyroid peroxidase AB: Roche Electrochemiluminescence Immunoassay (ECLIA)
Complement C3, Complement C4: Roche COBAS Immunoturbidimetric
Rheumatoid factor, quant: Roche COBAS immunoturbidimetric (WHO standard 64/2 traceable)

Rejection Criteria

Moderate or greater hemolysis
Avoid repeated freeze/thaw cycles

Reference Range(s)

By Report

Specimen Requirements

Preferred Specimen

Serum Seperator Tube

Minimum Volume

4 mL Serum

Sample Stability

Anti-nuclear antibodies, CCP IgG, DNA ds antibody: 1 day room temperature
1 week refrigerated
1 month frozen
Autoimmune antibodies: 1 week refrigerated
6 months frozen
Thyroid peroxidase AB: 8 days room temperature
8 days refrigerated
6 months frozen
Complement C3: 4 days room temperature
8 days refrigerated
8 days frozen
Complement C4: 2 days room temperature
8 days refrigerated
3 months frozen
Rheumatoid factor, quant: 1 day room temperature
8 days refrigerated
3 months frozen

Transport Temperature

Refrigerated

Collection Instructions

Allow SST to clot in an upright position for at least 30 minutes, then centrifuge sample within 2 hours of collection. Refrigerate.

Alternative Specimen

Collect 2 plain red top tubes. Allow samples to clot in an upright position for at least 60 minutes, then centrifuge samples and transfer serum to 2 plastic transport tubes. Clearly label tubes as serum from a plain red top tube. Refrigerate.
Note: Do not collect samples from patients receiving therapy with high biotin doses (>5 mg/day) until at least 8 hours following the last biotin administration.